148 related articles for article (PubMed ID: 10075910)
1. Use of parvovirus-like particles for vaccination and induction of multiple immune responses.
Casal JI
Biotechnol Appl Biochem; 1999 Apr; 29(2):141-50. PubMed ID: 10075910
[TBL] [Abstract][Full Text] [Related]
2. Engineering parvovirus-like particles for the induction of B-cell, CD4(+) and CTL responses.
Rueda P; Martínez-Torrecuadrada JL; Sarraseca J; Sedlik C; del Barrio M; Hurtado A; Leclerc C; Casal JI
Vaccine; 1999 Sep; 18(3-4):325-32. PubMed ID: 10506659
[TBL] [Abstract][Full Text] [Related]
3. Intranasal delivery of recombinant parvovirus-like particles elicits cytotoxic T-cell and neutralizing antibody responses.
Sedlik C; Dridi A; Deriaud E; Saron MF; Rueda P; Sarraseca J; Casal JI; Leclerc C
J Virol; 1999 Apr; 73(4):2739-44. PubMed ID: 10074120
[TBL] [Abstract][Full Text] [Related]
4. Minor displacements in the insertion site provoke major differences in the induction of antibody responses by chimeric parvovirus-like particles.
Rueda P; Hurtado A; del Barrio M; Martínez-Torrecuadrada JL; Kamstrup S; Leclerc C; Casal JI
Virology; 1999 Oct; 263(1):89-99. PubMed ID: 10544085
[TBL] [Abstract][Full Text] [Related]
5. Self-assembly of virus-like particles of canine parvovirus capsid protein expressed from Escherichia coli and application as virus-like particle vaccine.
Xu J; Guo HC; Wei YQ; Dong H; Han SC; Ao D; Sun DH; Wang HM; Cao SZ; Sun SQ
Appl Microbiol Biotechnol; 2014 Apr; 98(8):3529-38. PubMed ID: 24413974
[TBL] [Abstract][Full Text] [Related]
6. Canine parvovirus VP2 protein expressed in silkworm pupae self-assembles into virus-like particles with high immunogenicity.
Feng H; Hu GQ; Wang HL; Liang M; Liang H; Guo H; Zhao P; Yang YJ; Zheng XX; Zhang ZF; Zhao YK; Gao YW; Yang ST; Xia XZ
PLoS One; 2014; 9(1):e79575. PubMed ID: 24465364
[TBL] [Abstract][Full Text] [Related]
7. [Construction and immunogenicity of recombinant porcine parvovirus-like particles with somatostatin].
Zhang X; Zheng Q; Chen J; Xue G; Hou H; Hou J
Sheng Wu Gong Cheng Xue Bao; 2010 Aug; 26(8):1057-67. PubMed ID: 21090109
[TBL] [Abstract][Full Text] [Related]
8. Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles.
Rueda P; Fominaya J; Langeveld JP; Bruschke C; Vela C; Casal JI
Vaccine; 2000 Nov; 19(7-8):726-34. PubMed ID: 11115693
[TBL] [Abstract][Full Text] [Related]
9. Protective humoral immunity in guinea pigs induced by PCV2 virus-like particles displaying the B cell linear epitope (
Wang N; Zhang S; Wang D; Li F; Liang L; Li X; Zou Y; Zhan Y; Chen G; Yu W; Deng Z; Tu D; Cui S
Vet Microbiol; 2019 Aug; 235():86-92. PubMed ID: 31282383
[TBL] [Abstract][Full Text] [Related]
10. Influence of minor displacements in loops of the porcine parvovirus VP2 capsid on virus-like particles assembly and the induction of antibody responses.
Pan Q; He K; Wang Y; Wang X; Ouyang W
Virus Genes; 2013 Jun; 46(3):465-72. PubMed ID: 23430711
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of virus-like particles containing modified goose parvovirus VP2 protein.
Chen Z; Li C; Zhu Y; Wang B; Meng C; Liu G
Virus Res; 2012 Oct; 169(1):306-9. PubMed ID: 22940567
[TBL] [Abstract][Full Text] [Related]
12. Development and evaluation of a competitive ELISA using a monoclonal antibody for antibody detection after goose parvovirus virus-like particles (VLPs) and vaccine immunization in goose sera.
Wang Q; Ju H; Li Y; Jing Z; Guo L; Zhao Y; Ma B; Gao M; Zhang W; Wang J
J Virol Methods; 2014 Dec; 209():69-75. PubMed ID: 25196452
[TBL] [Abstract][Full Text] [Related]
13. Influence of flanking sequences on presentation efficiency of a CD8+ cytotoxic T-cell epitope delivered by parvovirus-like particles.
Rueda P; Morón G; Sarraseca J; Leclerc C; Casal JI
J Gen Virol; 2004 Mar; 85(Pt 3):563-572. PubMed ID: 14993639
[TBL] [Abstract][Full Text] [Related]
14. Goose parvovirus structural proteins expressed by recombinant baculoviruses self-assemble into virus-like particles with strong immunogenicity in goose.
Ju H; Wei N; Wang Q; Wang C; Jing Z; Guo L; Liu D; Gao M; Ma B; Wang J
Biochem Biophys Res Commun; 2011 May; 409(1):131-6. PubMed ID: 21554858
[TBL] [Abstract][Full Text] [Related]
15. Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus.
Luo J; Shi H; Tan Y; Niu X; Long T; Zhao J; Tian Q; Wang Y; Chen H; Guo X
Vaccine; 2016 Aug; 34(37):4392-8. PubMed ID: 27449079
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
[TBL] [Abstract][Full Text] [Related]
17. The immunogenicity of the virus-like particles derived from the VP2 protein of porcine parvovirus.
Hua T; Zhang D; Tang B; Chang C; Liu G; Zhang X
Vet Microbiol; 2020 Sep; 248():108795. PubMed ID: 32827923
[TBL] [Abstract][Full Text] [Related]
18. Comparison of immune responses induced by porcine parvovirus virus-like particles and inactivated vaccine.
Tian W; Qiu Z; Cui Y; Zhang J; Ma X; Cui S; Zheng S
Pak J Pharm Sci; 2019 Jan; 32(1(Special)):377-382. PubMed ID: 30852473
[TBL] [Abstract][Full Text] [Related]
19. Trigger factor assisted self-assembly of canine parvovirus VP2 protein into virus-like particles in Escherichia coli with high immunogenicity.
Nan L; Liu Y; Ji P; Feng H; Chen C; Wang J; Liu D; Cui Y; Wang Y; Li Y; Zhou E; Zhang G
Virol J; 2018 Jun; 15(1):103. PubMed ID: 29921294
[TBL] [Abstract][Full Text] [Related]
20. Recombinant parvovirus-like particles as an antigen carrier: a novel nonreplicative exogenous antigen to elicit protective antiviral cytotoxic T cells.
Sedlik C; Saron M; Sarraseca J; Casal I; Leclerc C
Proc Natl Acad Sci U S A; 1997 Jul; 94(14):7503-8. PubMed ID: 9207121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
